Trials / Unknown
UnknownNCT02619916
MBCT and CBT for Depression in Patients After Cancer: a Randomized Controlled Trial
Individual Mindfulness-Based Cognitive Therapy (MBCT) and Individual Cognitive Behavioral Therapy (CBT) for Depression in Patients After Cancer: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 192 (estimated)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether mindfulness-based cognitive therapy (MBCT) and cognitive behavioral therapy (CBT) are effective in reducing depressive symptoms in patients after cancer
Detailed description
Cancer patients are prone to develop depressive symptoms, even after curative treatment. Conventional therapies such as cognitive behavioral therapy (CBT) and mindfulness-based cognitive therapy (MBCT) are frequently used for reducing these depressive symptoms in patients with medical conditions. However, until now evidence from proper designed randomized controlled trials regarding the effectiveness of both interventions in cancer survivors, is lacking. Therefore, our longitudinal study aims to investigate the effectiveness of CBT and MBCT in reducing depressive symptoms in cancer survivors. In addition, potential moderators and mediators of each intervention will be explored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mindfulness-Based Cognitive Therapy (MBCT) | The intervention consists of 8 weekly individual sessions of MBCT. Each session will be administered individually and will last 60 minutes |
| BEHAVIORAL | Cognitive Behavioral Therapy (CBT) | The intervention consists of 8 weekly individual sessions of CBT. Each session will be administered individually and will last 60 minutes. |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-09-01
- Completion
- 2018-09-01
- First posted
- 2015-12-02
- Last updated
- 2016-05-18
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02619916. Inclusion in this directory is not an endorsement.